Hybrid Treatment of a Ruptured Diverticulum of Kommerell

2010 ◽  
Vol 17 (6) ◽  
pp. 762-766 ◽  
Author(s):  
Jan Bosma ◽  
Alexander D. Montauban van Swijndregt ◽  
Anco C. Vahl
2013 ◽  
Vol 95 (4) ◽  
pp. e95-e96 ◽  
Author(s):  
Randolph H.L. Wong ◽  
Simon C.Y. Chow ◽  
Jerry K.H. Lok ◽  
Calvin S.H. Ng ◽  
Simon C.H. Yu ◽  
...  

VASA ◽  
2018 ◽  
Vol 47 (3) ◽  
pp. 235-241 ◽  
Author(s):  
Soon Cheon Lee ◽  
Jin Hyun Joh ◽  
Jeong-Hwan Chang ◽  
Hyung-Kee Kim ◽  
Jang Yong Kim ◽  
...  

Abstract. Background: Endovascular treatment is an alternative first-line management for peripheral artery disease (PAD). Hybrid treatment (HT) is defined as a combined treatment for patients with PAD using endovascular and open surgery, simultaneously performed in an operating room. The results of HT are reportedly good for multilevel revascularization (MR) in patients with chronic limb ischaemia, and even in older high-risk patients. The goal of this study was to examine the clinical and haemodynamic outcomes of HT in patients who need MR. Patients and methods: Nine university hospitals in Korea participated in this multicentre study. A total of 134 patients with multilevel PAD underwent HT and MR. Patients were enrolled from July 2014 to June 2015 and were followed for 18 months. Results: The mean age of the patients was 68.8 ± 9.93 years and 88.1 % were men. Patients with Rutherford category 2 to 3 and 4 to 6 comprised 59.0 % and 42.0 % of the group, respectively. The technical success rate was 100 %. The primary patency rates at 12 and 18 months were 77.6 % and 63.9 %, respectively. The primary-assisted patency rates at 12 and 18 months were both 90.0 %. The pre-operative mean ankle brachial index (0.43 ± 0.23) increased to 0.87 ± 0.23 at six months post-operatively (t-test, p < 0.05). The amputation free survival rate was 97.1 %. Conclusions: Although outcomes of multilevel PAD are reportedly poor when endovascular treatment alone is used, we have shown that HT is a feasible alternative modality for patients with multilevel PAD, with satisfactory amputation-free survival and freedom from re-intervention rates.


2006 ◽  
Vol 9 (1) ◽  
pp. E530-E532
Author(s):  
Friedrich-Christian Riess ◽  
Hans Krankenberg ◽  
Thilo Tübler ◽  
Matthias Danne

2021 ◽  
Vol 278 ◽  
pp. 122444
Author(s):  
Sk Faisal Kabir ◽  
Suja Sukumaran ◽  
Sara Moghtadernejad ◽  
Ehsan Barjasteh ◽  
Elham H. Fini

2021 ◽  
Vol 169 ◽  
pp. 107965
Author(s):  
Tainá F. Ferreira ◽  
Patrick A. Santos ◽  
Ariela V. Paula ◽  
Heizir F. de Castro ◽  
Grazielle S.S. Andrade

Open Medicine ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. 890-897
Author(s):  
Francesco Stillo ◽  
Federica Ruggiero ◽  
Antonio De Fiores ◽  
Rita Compagna ◽  
Bruno Amato

AbstractBackgroundFirst identified in 2014, fibroadipose vascular anomaly (FAVA) is a very rare type of venous and lymphatic malformation. Marked by tough fibrofatty tissue in the extremities overtaking portions of the muscles, it is associated with constant pain and contracture of the affected extremity. There is a paucity of literature, and no guidelines on treatment procedure are available. This case highlights the role of hybrid treatment with primary ethanol percutaneous ethanol embolization and additional surgery for radicality in excision of FAVA lesions.Case summaryA 9-year-old girl with FAVA underwent the hybrid treatment. The achievements of complete excision, clinical response, and patient satisfaction in long-term follow-up were assessed. Following the hybrid treatment, the patient experienced significant improvement in pain. Concurrent symptoms of physical limitation, leg swelling, and skin hyperesthesia also improved. The clinical benefit, supported by postoperative physiotherapy, was well stabilized at 6-month follow-up, resulting in complete patient satisfaction at 12- and 36-month follow-ups. No major complications were encountered.ConclusionEthanol embolization plus surgery is a safe, effective, and long-term hybrid treatment of symptomatic FAVA lesions.


Surgery Today ◽  
2012 ◽  
Vol 42 (10) ◽  
pp. 1019-1021 ◽  
Author(s):  
Hideyuki Shimizu ◽  
Kazuma Okamoto ◽  
Kentaro Yamabe ◽  
Soshu Kotani ◽  
Ryohei Yozu

2017 ◽  
Vol 9 (1) ◽  
pp. 82
Author(s):  
A. Rollin ◽  
B. Marcheix ◽  
P. Mondoly ◽  
A. Duparc ◽  
C. Cardin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document